Androgen receptor splice variants circumvent AR blockade by microtubule-targeting agents

Docetaxel-based chemotherapy is established as a first-line treatment and standard of care for patients with metastatic castration-resistant prostate cancer. However, half of the patients do not respond to treatment and those do respond eventually become refractory. A better understanding of the res...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Oncotarget
Glavni autori: Zhang, Guanyi, Liu, Xichun, Li, Jianzhuo, Ledet, Elisa, Alvarez, Xavier, Qi, Yanfeng, Fu, Xueqi, Sartor, Oliver, Dong, Yan, Zhang, Haitao
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2015
Teme:
Research Paper
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4695123/
https://ncbi.nlm.nih.gov/pubmed/26160840
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items